{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:32:47Z","timestamp":1791592367645,"version":"4.3.4"},"reference-count":92,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:00:00Z","timestamp":1751414400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Deanship of Scientific Research at Jouf University","award":["DSR2022-RG-0152"],"award-info":[{"award-number":["DSR2022-RG-0152"]}]},{"DOI":"10.13039\/100002590","name":"American Lung Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012397","name":"Texas Biomedical Forum","doi-asserted-by":"publisher","award":["1520001"],"award-info":[{"award-number":["1520001"]}],"id":[{"id":"10.13039\/100012397","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-06967-x","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T23:21:23Z","timestamp":1751412083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["In vitro antiviral activities of thymol and Limonin against influenza a viruses and SARS-CoV-2"],"prefix":"10.1038","volume":"15","author":[{"given":"Gomaa","family":"Mostafa-Hedeab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akram","family":"Hegazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim H.","family":"Eissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed M.","family":"Metwaly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hany Abdelfattah","family":"Elhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abozer Y.","family":"Eledrdery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sager Holyl","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaa Oqalaa E.","family":"Alibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fawaz O.","family":"Alenazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhannad Faleh Alanazi","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thamer Alshami","family":"Marghel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muharib","family":"Alruwaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaaeldin Mohamed","family":"Saad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahmoud","family":"Bayoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assem Mohamed","family":"El-Shazly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Martinez-Sobrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Mostafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,2]]},"reference":[{"key":"6967_CR1","doi-asserted-by":"crossref","unstructured":"Bar-On, Y. M., Flamholz, A., Phillips, R. & Milo, R. SARS-CoV-2 (COVID-19) by the numbers. Elife 9, e57309. (2020).","DOI":"10.7554\/eLife.57309"},{"key":"6967_CR2","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MCP.0b013e328351f8d4","volume":"18","author":"T Jartti","year":"2012","unstructured":"Jartti, T., Jartti, L., Ruuskanen, O. & S\u00f6derlund-Venermo, M. New respiratory viral infections. Curr. Opin. Pulm. Med. 18, 271\u2013278 (2012).","journal-title":"Curr. Opin. Pulm. Med."},{"key":"6967_CR3","doi-asserted-by":"crossref","unstructured":"Boncristiani, H., Criado, M. & Arruda, E. Respiratory viruses. Encyclopedia Microbiology 500. (2009).","DOI":"10.1016\/B978-012373944-5.00314-X"},{"key":"6967_CR4","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s13312-010-0005-6","volume":"47","author":"VM Vashishtha","year":"2010","unstructured":"Vashishtha, V. M. Current status of tuberculosis and acute respiratory infections in india: much more needs to be done! Indian Pediatr. 47, 88\u201389 (2010).","journal-title":"Indian Pediatr."},{"key":"6967_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1055\/s-0036-1584801","volume":"37","author":"C Peteranderl","year":"2016","unstructured":"Peteranderl, C., Herold, S. & Schmoldt, C. Human influenza virus infections. Semin Respir Crit. Care Med. 37, 487\u2013500. https:\/\/doi.org\/10.1055\/s-0036-1584801 (2016).","journal-title":"Semin Respir Crit. Care Med."},{"key":"6967_CR6","doi-asserted-by":"publisher","first-page":"S71","DOI":"10.1097\/INF.0b013e3181684d7c","volume":"27","author":"AD Osterhaus","year":"2008","unstructured":"Osterhaus, A. D. New respiratory viruses of humans. Pediatr. Infect. Dis. J. 27, S71\u2013S74 (2008).","journal-title":"Pediatr. Infect. Dis. J."},{"key":"6967_CR7","doi-asserted-by":"crossref","unstructured":"Abdelrahman, Z., Li, M. & Wang, X. Comparative review of SARS-CoV-2, SARS-CoV, MERS-CoV, and influenza a respiratory viruses. Frontiers Immunology 2309. (2020).","DOI":"10.3389\/fimmu.2020.552909"},{"key":"6967_CR8","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.2214\/AJR.20.23214","volume":"215","author":"Z Yin","year":"2020","unstructured":"Yin, Z. et al. A comparison of clinical and chest CT findings in patients with influenza A (H1N1) virus infection and coronavirus disease (COVID-19). Am. J. Roentgenol. 215, 1065\u20131071 (2020).","journal-title":"Am. J. Roentgenol."},{"key":"6967_CR9","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1016\/S1473-3099(10)70120-1","volume":"10","author":"H Nishiura","year":"2010","unstructured":"Nishiura, H. Case fatality ratio of pandemic influenza. Lancet. Infect. Dis. 10, 443\u2013444 (2010).","journal-title":"Lancet. Infect. Dis"},{"key":"6967_CR10","doi-asserted-by":"crossref","unstructured":"Johnson, N. P. & Mueller, J. Updating the accounts: global mortality of the 1918\u20131920 Spanish influenza pandemic. Bulletin History Medicine 105\u2013115. (2002).","DOI":"10.1353\/bhm.2002.0022"},{"key":"6967_CR11","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1016\/S0140-6736(06)69895-4","volume":"368","author":"CJ Murray","year":"2006","unstructured":"Murray, C. J., Lopez, A. D., Chin, B., Feehan, D. & Hill, K. H. Estimation of potential global pandemic influenza mortality on the basis of vital registry data from the 1918\u201320 pandemic: a quantitative analysis. Lancet 368, 2211\u20132218 (2006).","journal-title":"Lancet"},{"key":"6967_CR12","doi-asserted-by":"publisher","unstructured":"Kumar, A. et al. Wuhan to world: the COVID-19 pandemic. Front. Cell. Infect. Microbiol. 11 https:\/\/doi.org\/10.3389\/fcimb.2021.596201 (2021).","DOI":"10.3389\/fcimb.2021.596201"},{"key":"6967_CR13","doi-asserted-by":"crossref","unstructured":"Enserink, M. & Cohen, J. The novel H1N1 influenza. (2009).","DOI":"10.1126\/science.326.5960.1607"},{"key":"6967_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-02185-4","author":"JV Lazarus","year":"2023","unstructured":"Lazarus, J. V. et al. A survey of COVID-19 vaccine acceptance across 23 countries in 2022. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-022-02185-4 (2023).","journal-title":"Nat. Med."},{"key":"6967_CR15","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/s41591-021-01301-0","volume":"27","author":"JL Excler","year":"2021","unstructured":"Excler, J. L., Saville, M., Berkley, S. & Kim, J. H. Vaccine development for emerging infectious diseases. Nat. Med. 27, 591\u2013600. https:\/\/doi.org\/10.1038\/s41591-021-01301-0 (2021).","journal-title":"Nat. Med."},{"key":"6967_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.coi.2016.06.002","volume":"42","author":"H Ren","year":"2016","unstructured":"Ren, H. & Zhou, P. Epitope-focused vaccine design against influenza A and B viruses. Curr. Opin. Immunol. 42, 83\u201390 (2016).","journal-title":"Curr. Opin. Immunol."},{"key":"6967_CR17","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.arcmed.2020.09.013","volume":"52","author":"K Baby","year":"2021","unstructured":"Baby, K. et al. Targeting SARS-CoV-2 main protease: a computational drug repurposing study. Arch. Med. Res. 52, 38\u201347 (2021).","journal-title":"Arch. Med. Res."},{"key":"6967_CR18","doi-asserted-by":"publisher","first-page":"101147","DOI":"10.1016\/j.imu.2022.101147","volume":"36","author":"N Shahabadi","year":"2023","unstructured":"Shahabadi, N., Zendehcheshm, S., Mahdavi, M. & Khademi, F. Repurposing FDA-approved drugs cetilistat, abiraterone, diiodohydroxyquinoline, bexarotene, and Remdesivir as potential inhibitors against RNA dependent RNA polymerase of SARS-CoV-2: A comparative in Silico perspective. Inf. Med. Unlocked. 36, 101147 (2023).","journal-title":"Inf. Med. Unlocked"},{"key":"6967_CR19","doi-asserted-by":"publisher","first-page":"795","DOI":"10.3390\/molecules28020795","volume":"28","author":"S Shoaib","year":"2023","unstructured":"Shoaib, S. et al. An attention towards the prophylactic and therapeutic options of phytochemicals for SARS-CoV-2: A molecular insight. Molecules 28, 795 (2023).","journal-title":"Molecules"},{"key":"6967_CR20","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3389\/fimmu.2019.00060","volume":"10","author":"A Pizzorno","year":"2019","unstructured":"Pizzorno, A. et al. Repurposing of drugs as novel influenza inhibitors from clinical gene expression infection signatures. Front. Immunol. 10, 60 (2019).","journal-title":"Front. Immunol."},{"key":"6967_CR21","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1021\/acs.jnatprod.5b01055","volume":"79","author":"DJ Newman","year":"2016","unstructured":"Newman, D. J. & Cragg, G. M. Natural products as sources of new drugs from 1981 to 2014. J. Nat. Prod. 79, 629\u2013661 (2016).","journal-title":"J. Nat. Prod."},{"key":"6967_CR22","doi-asserted-by":"crossref","unstructured":"Shokry, S.; Hegazy, A.; Abbas, A.M.; Mostafa, I.; Eissa, I.H.; Metwaly, A.M.; Yahya,G.; El-Shazly, A.M.; Aboshanab, K.M.; Mostafa, A. Phytoestrogen \u03b2-Sitosterol Exhibits Potent In Vitro Antiviral Activity against Influenza A Viruses. Vaccines 2023, 11, 228.","DOI":"10.3390\/vaccines11020228"},{"key":"6967_CR23","doi-asserted-by":"publisher","first-page":"41212","DOI":"10.1021\/acsomega.2c04867","volume":"7","author":"A Hegazy","year":"2022","unstructured":"Hegazy, A. et al. Robust antiviral activity of Santonica flower extract (Artemisia cina) against avian and human influenza A viruses: in vitro and chemoinformatic studies. ACS Omega. 7, 41212\u201341223. https:\/\/doi.org\/10.1021\/acsomega.2c04867 (2022).","journal-title":"ACS Omega"},{"key":"6967_CR24","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1038\/s41598-023-27954-0","volume":"13","author":"A Hegazy","year":"2023","unstructured":"Hegazy, A. et al. Antiviral activities of plant-derived Indole and \u03b2-carboline alkaloids against human and avian influenza viruses. Sci. Rep. 13, 1612. https:\/\/doi.org\/10.1038\/s41598-023-27954-0 (2023).","journal-title":"Sci. Rep."},{"key":"6967_CR25","doi-asserted-by":"publisher","unstructured":"Chouhan, S., Sharma, K. & Guleria, S. Antimicrobial activity of some essential Oils-Present status and future perspectives. Med. (Basel). 4 https:\/\/doi.org\/10.3390\/medicines4030058 (2017).","DOI":"10.3390\/medicines4030058"},{"key":"6967_CR26","doi-asserted-by":"publisher","unstructured":"Bunse, M. et al. Essential oils as multicomponent mixtures and their potential for human health and Well-Being. Front. Pharmacol. 13 https:\/\/doi.org\/10.3389\/fphar.2022.956541 (2022).","DOI":"10.3389\/fphar.2022.956541"},{"key":"6967_CR27","doi-asserted-by":"publisher","first-page":"e00352","DOI":"10.1016\/j.susmat.2021.e00352","volume":"30","author":"D Pathania","year":"2021","unstructured":"Pathania, D. et al. Essential oil derived biosynthesis of metallic nano-particles: implementations above essence. Sustainable Mater. Technol. 30, e00352 (2021).","journal-title":"Sustainable Mater. Technol."},{"key":"6967_CR28","doi-asserted-by":"crossref","unstructured":"Li, Y., Fabiano-Tixier, A. S. & Chemat, F. Essential oils as reagents in green chemistry; Springer: ; Volume 1. (2014).","DOI":"10.1007\/978-3-319-08449-7_1"},{"key":"6967_CR29","doi-asserted-by":"publisher","first-page":"70","DOI":"10.3390\/molecules22010070","volume":"22","author":"J Sharifi-Rad","year":"2017","unstructured":"Sharifi-Rad, J. et al. Biological activities of essential oils: from plant chemoecology to traditional healing systems. Molecules 22, 70 (2017).","journal-title":"Molecules"},{"key":"6967_CR30","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/j.jiph.2019.01.058","volume":"12","author":"K El Omari","year":"2019","unstructured":"El Omari, K. et al. In-vitro evaluation of the antibacterial activity of the essential oils of Micromeria barbata, Eucalyptus globulus and Juniperus excelsa against strains of Mycobacterium tuberculosis (including MDR), Mycobacterium kansasii and Mycobacterium gordonae. J. Infect. Public Health. 12, 615\u2013618 (2019).","journal-title":"J. Infect. Public Health"},{"key":"6967_CR31","doi-asserted-by":"crossref","unstructured":"Elshafie, H. S. & Camele, I. An overview of the biological effects of some mediterranean essential oils on human health. BioMed research international 2017. (2017).","DOI":"10.1155\/2017\/9268468"},{"key":"6967_CR32","doi-asserted-by":"crossref","unstructured":"Seol, G. H. & Kim, K. Y. Eucalyptol and its role in chronic diseases. Drug Discovery Mother. Nature 389\u2013398. (2016).","DOI":"10.1007\/978-3-319-41342-6_18"},{"key":"6967_CR33","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1472-8206.2012.01067.x","volume":"27","author":"AL Rozza","year":"2013","unstructured":"Rozza, A. L. & Pellizzon, C. H. Essential oils from medicinal and aromatic plants: a review of the gastroprotective and ulcer-healing activities. Fundam. Clin. Pharmacol. 27, 51\u201363 (2013).","journal-title":"Fundam. Clin. Pharmacol."},{"key":"6967_CR34","doi-asserted-by":"crossref","unstructured":"Buckle, J. Clinical aromatherapy-e-book: essential oils in practice; Elsevier Health Sciences: (2014).","DOI":"10.1016\/B978-0-7020-5440-2.00002-4"},{"key":"6967_CR35","doi-asserted-by":"crossref","unstructured":"Kandeil, A. et al. Coding-Complete genome sequences of two SARS-CoV-2 isolates from Egypt. Microbiol. Resource Announcements. 9 (2020).","DOI":"10.1128\/MRA.00489-20"},{"key":"6967_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1093\/oxfordjournals.aje.a118408","volume":"27","author":"LJ Reed","year":"1938","unstructured":"Reed, L. J. & Muench, H. A simple method of estimating Fifty per cent endpoints. Am. J. Epidemiol. 27, 493\u2013497 (1938).","journal-title":"Am. J. Epidemiol."},{"key":"6967_CR37","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.foodchem.2010.12.129","volume":"127","author":"D Hamdan","year":"2011","unstructured":"Hamdan, D. et al. Chemical composition and biological activity of Citrus jambhiri lush. Food Chem. 127, 394\u2013403. https:\/\/doi.org\/10.1016\/j.foodchem.2010.12.129 (2011).","journal-title":"Food Chem."},{"key":"6967_CR38","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1078\/094471103322331467","volume":"10","author":"A Schuhmacher","year":"2003","unstructured":"Schuhmacher, A., Reichling, J. & Schnitzler, P. Virucidal effect of peppermint oil on the enveloped viruses herpes simplex virus type 1 and type 2 in vitro. Phytomedicine 10, 504\u2013510 (2003).","journal-title":"Phytomedicine"},{"key":"6967_CR39","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1208\/s12249-009-9242-1","volume":"10","author":"S Rajan","year":"2009","unstructured":"Rajan, S. Development of novel microemulsion-based topical formulations of acyclovir for the treatment of cutaneous herpetic infections. AAPS PharmSciTech. 10, 559\u2013565 (2009).","journal-title":"AAPS PharmSciTech"},{"key":"6967_CR40","doi-asserted-by":"publisher","first-page":"e0200902","DOI":"10.1371\/journal.pone.0200902","volume":"13","author":"A Rosato","year":"2018","unstructured":"Rosato, A. et al. Elucidation of the synergistic action of Mentha Piperita essential oil with common antimicrobials. PloS One. 13, e0200902 (2018).","journal-title":"PloS One"},{"key":"6967_CR41","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s00284-007-9045-0","volume":"56","author":"C Cermelli","year":"2008","unstructured":"Cermelli, C., Fabio, A., Fabio, G. & Quaglio, P. Effect of eucalyptus essential oil on respiratory bacteria and viruses. Curr. Microbiol. 56, 89\u201392 (2008).","journal-title":"Curr. Microbiol."},{"key":"6967_CR42","doi-asserted-by":"publisher","first-page":"e00459","DOI":"10.1002\/mbo3.459","volume":"6","author":"A Brochot","year":"2017","unstructured":"Brochot, A., Guilbot, A., Haddioui, L. & Roques, C. Antibacterial, antifungal, and antiviral effects of three essential oil blends. Microbiologyopen 6, e00459 (2017).","journal-title":"Microbiologyopen"},{"key":"6967_CR43","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1002\/ptr.2226","volume":"21","author":"Y Tragoolpua","year":"2007","unstructured":"Tragoolpua, Y. & Jatisatienr, A. Anti-herpes simplex virus activities of Eugenia caryophyllus (Spreng.) Bullock & SG Harrison and essential oil, Eugenol. Phytotherapy Research: Int. J. Devoted Pharmacol. Toxicol. Evaluation Nat. Prod. Derivatives. 21, 1153\u20131158 (2007).","journal-title":"Phytotherapy Research: Int. J. Devoted Pharmacol. Toxicol. Evaluation Nat. Prod. Derivatives"},{"key":"6967_CR44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.3390\/biom10020202","volume":"10","author":"G El-Saber Batiha","year":"2020","unstructured":"El-Saber Batiha, G. et al. Syzygium aromaticum L.(Myrtaceae): traditional uses, bioactive chemical constituents, Pharmacological and toxicological activities. Biomolecules 10, 202 (2020).","journal-title":"Biomolecules"},{"key":"6967_CR45","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1080\/13880209.2017.1314513","volume":"55","author":"X Han","year":"2017","unstructured":"Han, X. & Parker, T. L. Anti-inflammatory activity of clove (Eugenia caryophyllata) essential oil in human dermal fibroblasts. Pharm. Biol. 55, 1619\u20131622 (2017).","journal-title":"Pharm. Biol."},{"key":"6967_CR46","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.bbrc.2017.04.009","volume":"491","author":"Y Li","year":"2017","unstructured":"Li, Y. et al. -w. Thymol inhibits bladder cancer cell proliferation via inducing cell cycle arrest and apoptosis. Biochem. Biophys. Res. Commun. 491, 530\u2013536 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"6967_CR47","doi-asserted-by":"publisher","first-page":"1636","DOI":"10.1055\/s-0032-1315208","volume":"78","author":"WL Lai","year":"2012","unstructured":"Lai, W. L. et al. Inhibition of herpes simplex virus type 1 by thymol-related monoterpenoids. Planta Med. 78, 1636\u20131638 (2012).","journal-title":"Planta Med."},{"key":"6967_CR48","doi-asserted-by":"publisher","first-page":"128823","DOI":"10.1016\/j.molstruc.2020.128823","volume":"1221","author":"SA Kulkarni","year":"2020","unstructured":"Kulkarni, S. A. et al. Computational evaluation of major components from plant essential oils as potent inhibitors of SARS-CoV-2 Spike protein. J. Mol. Struct. 1221, 128823 (2020).","journal-title":"J. Mol. Struct."},{"key":"6967_CR49","first-page":"47","volume":"2","author":"S Vimalanathan","year":"2014","unstructured":"Vimalanathan, S. & Hudson, J. Anti-influenza virus activity of essential oils and vapors. Am. J. Essent. Oils Nat. Prod. 2, 47\u201353 (2014).","journal-title":"Am. J. Essent. Oils Nat. Prod."},{"key":"6967_CR50","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1515\/znc-2020-0051","volume":"76","author":"N Karaca","year":"2021","unstructured":"Karaca, N., \u015eener, G., Demirci, B. & Demirci, F. Synergistic antibacterial combination of Lavandula latifolia medik. Essential oil with Camphor. Z. F\u00fcr Naturforschung C. 76, 169\u2013173 (2021).","journal-title":"Z. F\u00fcr Naturforschung C"},{"key":"6967_CR51","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1039\/C8MD00442K","volume":"9","author":"KS Kovaleva","year":"2018","unstructured":"Kovaleva, K. S. et al. Synthesis of D-(+)-camphor-based N-acylhydrazones and their antiviral activity. Medchemcomm 9, 2072\u20132082 (2018).","journal-title":"Medchemcomm"},{"key":"6967_CR52","first-page":"320","volume":"14","author":"AJ Abd","year":"2019","unstructured":"Abd, A. J., Al-Shammarie Ahmed, M. & Abd, A. H. H. Antiviral activity of Limonin against Newcastle disease virus in vitro. Res. J. Biotechnol. 14, 320\u2013328 (2019).","journal-title":"Res. J. Biotechnol."},{"key":"6967_CR53","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.3390\/molecules21111530","volume":"21","author":"R Gualdani","year":"2016","unstructured":"Gualdani, R., Cavalluzzi, M. M., Lentini, G. & Habtemariam, S. The chemistry and Pharmacology of Citrus limonoids. Molecules 21, 1530 (2016).","journal-title":"Molecules"},{"key":"6967_CR54","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1039\/C3FO30325J","volume":"4","author":"KN Chidambara Murthy","year":"2013","unstructured":"Chidambara Murthy, K. N., Jayaprakasha, G. K. & Patil, B. S. Citrus limonoids and Curcumin additively inhibit human colon cancer cells. Food Funct. 4, 803\u2013810. https:\/\/doi.org\/10.1039\/C3FO30325J (2013).","journal-title":"Food Funct."},{"key":"6967_CR55","doi-asserted-by":"publisher","first-page":"3679","DOI":"10.3390\/molecules24203679","volume":"24","author":"S Fan","year":"2019","unstructured":"Fan, S. et al. Limonin: A review of its pharmacology, toxicity, and pharmacokinetics. Molecules 24, 3679 (2019).","journal-title":"Molecules"},{"key":"6967_CR56","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1055\/s-2003-45099","volume":"69","author":"L Battinelli","year":"2003","unstructured":"Battinelli, L. et al. Effect of Limonin and nomilin on HIV-1 replication on infected human mononuclear cells. Planta Med. 69, 910\u2013913 (2003).","journal-title":"Planta Med."},{"key":"6967_CR57","doi-asserted-by":"publisher","first-page":"110622","DOI":"10.1016\/j.biopha.2020.110622","volume":"131","author":"AA Berretta","year":"2020","unstructured":"Berretta, A. A., Silveira, M. A. D., Capcha, J. M. C. & De Jong, D. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: running title: Propolis against SARS-CoV-2 infection and COVID-19. Biomed. Pharmacother. 131, 110622 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"6967_CR58","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1248\/cpb.57.1246","volume":"57","author":"C Chansriniyom","year":"2009","unstructured":"Chansriniyom, C., Ruangrungsi, N., Lipipun, V., Kumamoto, T. & Ishikawa, T. Isolation of acridone alkaloids and N-[(4-monoterpenyloxy) phenylethyl]-substituted sulfur-containing propanamide derivatives from Glycosmis Parva and their anti-herpes simplex virus activity. Chem. Pharm. Bull. 57, 1246\u20131250 (2009).","journal-title":"Chem. Pharm. Bull."},{"key":"6967_CR59","doi-asserted-by":"publisher","first-page":"e07962","DOI":"10.1016\/j.heliyon.2021.e07962","volume":"7","author":"A Mahmoud","year":"2021","unstructured":"Mahmoud, A. et al. Telaprevir is a potential drug for repurposing against SARS-CoV-2: computational and in vitro studies. Heliyon 7, e07962 (2021).","journal-title":"Heliyon"},{"key":"6967_CR60","doi-asserted-by":"publisher","first-page":"443","DOI":"10.3390\/ph13120443","volume":"13","author":"A Mostafa","year":"2020","unstructured":"Mostafa, A. et al. FDA-approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals 13, 443 (2020).","journal-title":"Pharmaceuticals"},{"key":"6967_CR61","doi-asserted-by":"publisher","unstructured":"Mostafa, A. et al. FDA-Approved drugs with potent in vitro antiviral activity against severe acute respiratory syndrome coronavirus 2. Pharmaceuticals (Basel Switzerland). 13 https:\/\/doi.org\/10.3390\/ph13120443 (2020).","DOI":"10.3390\/ph13120443"},{"key":"6967_CR62","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1128\/am.16.4.588-594.1968","volume":"16","author":"CR Gaush","year":"1968","unstructured":"Gaush, C. R. & Smith, T. F. Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl. Microbiol. 16, 588\u2013594 (1968).","journal-title":"Appl. Microbiol."},{"key":"6967_CR63","doi-asserted-by":"publisher","unstructured":"Bayoumi, M. et al. Identification of amino acid residues responsible for differential replication and pathogenicity of avian influenza virus H5N1 isolated from human and cattle in texas, US. bioRxiv 2025, 2025.2003.2001.640810, https:\/\/doi.org\/10.1101\/2025.03.01.640810","DOI":"10.1101\/2025.03.01.640810"},{"key":"6967_CR64","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.3390\/molecules26092806","volume":"26","author":"MS Alesawy","year":"2021","unstructured":"Alesawy, M. S. et al. In Silico studies of some isoflavonoids as potential candidates against COVID-19 targeting human ACE2 (hACE2) and viral main protease (Mpro). Molecules 26, 2806 (2021).","journal-title":"Molecules"},{"key":"6967_CR65","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1080\/14756366.2021.1883598","volume":"36","author":"M Hagras","year":"2021","unstructured":"Hagras, M. et al. Discovery of new Quinolines as potent Colchicine binding site inhibitors: design, synthesis, Docking studies, and anti-proliferative evaluation. J. Enzyme Inhib. Med. Chem. 36, 640\u2013658 (2021).","journal-title":"J. Enzyme Inhib. Med. Chem."},{"key":"6967_CR66","doi-asserted-by":"publisher","first-page":"104949","DOI":"10.1016\/j.bioorg.2021.104949","volume":"112","author":"MM Alanazi","year":"2021","unstructured":"Alanazi, M. M. et al. New Bis ([1, 2, 4] triazolo)[4, 3-a: 3\u2032, 4\u2032-c] Quinoxaline derivatives as VEGFR-2 inhibitors and apoptosis inducers: design, synthesis, in Silico studies, and anticancer evaluation. Bioorg. Chem. 112, 104949 (2021).","journal-title":"Bioorg. Chem."},{"key":"6967_CR67","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1021\/ci500081m","volume":"54","author":"Y Li","year":"2014","unstructured":"Li, Y., Han, L., Liu, Z. & Wang, R. Comparative assessment of scoring functions on an updated benchmark: 2. Evaluation methods and general results. J. Chem. Inf. Model. 54, 1717\u20131736 (2014).","journal-title":"J. Chem. Inf. Model."},{"key":"6967_CR68","doi-asserted-by":"publisher","first-page":"86","DOI":"10.5958\/0974-4150.2021.00014.6","volume":"14","author":"SS Pawar","year":"2021","unstructured":"Pawar, S. S. & Rohane, S. H. Review on discovery studio: an important tool for molecular Docking. Asian J. Res. Chem. 14, 86\u201388 (2021).","journal-title":"Asian J. Res. Chem."},{"key":"6967_CR69","doi-asserted-by":"publisher","first-page":"16949","DOI":"10.1039\/D1NJ02509K","volume":"45","author":"RG Yousef","year":"2021","unstructured":"Yousef, R. G. et al. New quinoxaline-2 (1 H)-ones as potential VEGFR-2 inhibitors: design, synthesis, molecular docking, ADMET profile and anti-proliferative evaluations. New J. Chem. 45, 16949\u201316964 (2021).","journal-title":"New J. Chem."},{"key":"6967_CR70","doi-asserted-by":"publisher","first-page":"6593","DOI":"10.3390\/molecules26216593","volume":"26","author":"MS Alesawy","year":"2021","unstructured":"Alesawy, M. S., Elkaeed, E. B., Alsfouk, A. A., Metwaly, A. M. & Eissa, I. H. In Silico screening of semi-synthesized compounds as potential inhibitors for SARS-CoV-2 papain-like protease: pharmacophoric features, molecular docking, ADMET, toxicity and DFT studies. Molecules 26, 6593 (2021).","journal-title":"Molecules"},{"key":"6967_CR71","doi-asserted-by":"publisher","unstructured":"Shokry, S. et al. Phytoestrogen \u03b2-Sitosterol exhibits potent in vitro antiviral activity against influenza A viruses. Vaccines 11 https:\/\/doi.org\/10.3390\/vaccines11020228 (2023).","DOI":"10.3390\/vaccines11020228"},{"key":"6967_CR72","doi-asserted-by":"publisher","unstructured":"Barakat, A. et al. Synthesis and in vitro evaluation of Spirooxindole-Based phenylsulfonyl moiety as a candidate Anti-SAR-CoV-2 and MERS-CoV-2 with the implementation of combination studies. Int. J. Mol. Sci. 23 https:\/\/doi.org\/10.3390\/ijms231911861 (2022).","DOI":"10.3390\/ijms231911861"},{"key":"6967_CR73","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrmicro3475","volume":"13","author":"F Vigant","year":"2015","unstructured":"Vigant, F., Santos, N. C. & Lee, B. Broad-spectrum antivirals against viral fusion. Nat. Rev. Microbiol. 13, 426\u2013437 (2015).","journal-title":"Nat. Rev. Microbiol."},{"key":"6967_CR74","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.hermed.2018.02.003","volume":"13","author":"E Lenz","year":"2018","unstructured":"Lenz, E. et al. Authorised medicinal product Aspecton\u00ae oral drops containing thyme extract KMTv24497 shows antiviral activity against viruses which cause respiratory infections. J. Herb. Med. 13, 26\u201333. https:\/\/doi.org\/10.1016\/j.hermed.2018.02.003 (2018).","journal-title":"J. Herb. Med."},{"key":"6967_CR75","first-page":"98","volume":"18","author":"T Nandi","year":"2022","unstructured":"Nandi, T. & Khanna, M. Anti-Viral activity of thymol against influenza A virus. EC Microbiol. 18, 98\u2013103 (2022).","journal-title":"EC Microbiol."},{"key":"6967_CR76","doi-asserted-by":"crossref","unstructured":"Seadawy, M. G. et al. A.R.N. In vitro: natural compounds (Thymol, Carvacrol, Hesperidine, and Thymoquinone) against Sars-Cov2 strain isolated from Egyptian patients. bioRxiv 2020.2011. 2007.367649. (2020).","DOI":"10.21203\/rs.3.rs-101405\/v1"},{"key":"6967_CR77","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1002\/ffj.3165","volume":"28","author":"NY Saad","year":"2013","unstructured":"Saad, N. Y., Muller, C. D. & Lobstein, A. Major bioactivities and mechanism of action of essential oils and their components. Flavour Fragr. J. 28, 269\u2013279 (2013).","journal-title":"Flavour Fragr. J."},{"key":"6967_CR78","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.3390\/ijms21103426","volume":"21","author":"JKR da Silva","year":"2020","unstructured":"da Silva, J. K. R., Figueiredo, P. L. B., Byler, K. G. & Setzer, W. N. Essential oils as antiviral agents, potential of essential oils to treat SARS-CoV-2 infection: an In-Silico investigation. Int. J. Mol. Sci. 21, 3426 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"6967_CR79","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/j.jtcme.2021.04.001","volume":"12","author":"S Vardhan","year":"2022","unstructured":"Vardhan, S. & Sahoo, S. K. Virtual screening by targeting proteolytic sites of Furin and TMPRSS2 to propose potential compounds obstructing the entry of SARS-CoV-2 virus into human host cells. J. Traditional Complement. Med. 12, 6\u201315 (2022).","journal-title":"J. Traditional Complement. Med."},{"key":"6967_CR80","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.ejmech.2016.10.035","volume":"127","author":"AS Sokolova","year":"2017","unstructured":"Sokolova, A. S. et al. Aliphatic and alicyclic Camphor Imines as effective inhibitors of influenza virus H1N1. Eur. J. Med. Chem. 127, 661\u2013670 (2017).","journal-title":"Eur. J. Med. Chem."},{"key":"6967_CR81","doi-asserted-by":"publisher","first-page":"6690","DOI":"10.1016\/j.bmc.2013.08.014","volume":"21","author":"AS Sokolova","year":"2013","unstructured":"Sokolova, A. S. et al. New quaternary ammonium Camphor derivatives and their antiviral activity, genotoxic effects and cytotoxicity. Bioorg. Med. Chem. 21, 6690\u20136698 (2013).","journal-title":"Bioorg. Med. Chem."},{"key":"6967_CR82","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.antiviral.2015.06.004","volume":"120","author":"V Zarubaev","year":"2015","unstructured":"Zarubaev, V. et al. Broad range of inhibiting action of novel camphor-based compound with anti-hemagglutinin activity against influenza viruses in vitro and in vivo. Antiviral Res. 120, 126\u2013133 (2015).","journal-title":"Antiviral Res."},{"key":"6967_CR83","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10593-021-02923-5","volume":"57","author":"KS Kovaleva","year":"2021","unstructured":"Kovaleva, K. S. et al. Synthesis and antiviral activity of N-heterocyclic hydrazine derivatives of Camphor and Fenchone. Chem. Heterocycl. Compd. 57, 455\u2013461 (2021).","journal-title":"Chem. Heterocycl. Compd."},{"key":"6967_CR84","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1080\/02786826.2012.708948","volume":"46","author":"OV Pyankov","year":"2012","unstructured":"Pyankov, O. V., Usachev, E. V., Pyankova, O. & Agranovski, I. E. Inactivation of airborne influenza virus by tea tree and Eucalyptus oils. Aerosol Sci. Technol. 46, 1295\u20131302. https:\/\/doi.org\/10.1080\/02786826.2012.708948 (2012).","journal-title":"Aerosol Sci. Technol."},{"key":"6967_CR85","doi-asserted-by":"publisher","first-page":"3718","DOI":"10.3390\/molecules27123718","volume":"27","author":"VN Madia","year":"2022","unstructured":"Madia, V. N. et al. Di santo, R. Ultrastructural damages to H1N1 influenza virus caused by vapor essential oils. Molecules 27, 3718 (2022).","journal-title":"Molecules"},{"key":"6967_CR86","doi-asserted-by":"publisher","first-page":"899","DOI":"10.3934\/microbiol.2017.4.899","volume":"3","author":"MS Sadatrasul","year":"2017","unstructured":"Sadatrasul, M. S. et al. Oil-in-water emulsion formulated with eucalyptus leaves extract inhibit influenza virus binding and replication in vitro. AIMS Microbiol. 3, 899 (2017).","journal-title":"AIMS Microbiol."},{"key":"6967_CR87","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1080\/14786419.2021.1944137","volume":"36","author":"B Najar","year":"2022","unstructured":"Najar, B. et al. Screening of the essential oil effects on human H1N1 influenza virus infection: an in vitro study in MDCK cells. Nat. Prod. Res. 36, 3149\u20133152 (2022).","journal-title":"Nat. Prod. Res."},{"key":"6967_CR88","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.3390\/ph14121210","volume":"14","author":"D Mieres-Castro","year":"2021","unstructured":"Mieres-Castro, D., Ahmar, S., Shabbir, R. & Mora-Poblete, F. Antiviral activities of eucalyptus essential oils: their effectiveness as therapeutic targets against human viruses. Pharmaceuticals 14, 1210 (2021).","journal-title":"Pharmaceuticals"},{"key":"6967_CR89","doi-asserted-by":"publisher","first-page":"5261","DOI":"10.2174\/1381612826666201015154611","volume":"26","author":"PJ Wilkin","year":"2020","unstructured":"Wilkin, P. J., Al-Yozbaki, M., George, A., Gupta, G. K. & Wilson, C. M. The undiscovered potential of essential oils for treating SARS-CoV-2 (COVID-19). Curr. Pharm. Design. 26, 5261\u20135277 (2020).","journal-title":"Curr. Pharm. Design"},{"key":"6967_CR90","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.3390\/molecules27051743","volume":"27","author":"P Gonz\u00e1lez-Maldonado","year":"2022","unstructured":"Gonz\u00e1lez-Maldonado, P. et al. Cantero-Gonz\u00e1lez, G. Screening of natural products inhibitors of SARS-CoV-2 entry. Molecules 27, 1743 (2022).","journal-title":"Molecules"},{"key":"6967_CR91","doi-asserted-by":"crossref","unstructured":"Sharma, A. D. & Kaur, I. Eucalyptus essential oil bioactive molecules from against SARS-CoV-2 Spike protein: insights from computational studies. (2021).","DOI":"10.21203\/rs.3.rs-140069\/v1"},{"key":"6967_CR92","first-page":"282","volume":"7","author":"A dev Sharma","year":"2021","unstructured":"dev Sharma, A. Homology modeling and molecular Docking of natural metabolites from eucalyptus essential oil against SARS-CoV-2 Spike protein. Arab. J. Med. Aromatic Plants. 7, 282\u2013303 (2021).","journal-title":"Arab. J. Med. Aromatic Plants"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06967-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06967-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T00:03:41Z","timestamp":1751414621000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-06967-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,2]]},"references-count":92,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6967"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-06967-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,2]]},"assertion":[{"value":"11 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22587"}}